Viktor Drvota

Chief Executive Officer at KDVENTURES AB

61 year

Health Technology

Commercial Services

Finance

Profile

Viktor Drvota is currently Chief Executive Officer at Karolinska Development AB (Private Equity) since 2017, Chairman & Chief Executive Officer at Umecrine Cognition AB starting 2025, Chief Executive Officer at KDventures AB starting 2025, Chairman at Modus Therapeutics AB, Chairman at Modus Therapeutics Holding AB since 2016, Chairman at KDev Investments AB since 2017, Director at Dilafor AB since 2016, Director at KDev Oncology AB, Director at Forendo Pharma Oy, Deputy Director at SVF Vaccines AB, Director at AnaCardio AB, Director at Dilafor Incentive AB, and Director at Uc Research AB. Former roles include Chairman at Flerie AB in 2011, Chairman at Airsonett AB from 2012 to 2013, Chairman at Scibase Intressenter AB, Chairman at InDex Diagnostics AB, Director at SBL Vaccin AB, Director at SciBase Holding AB, Director at Neoventa Medical AB, Director at Arexis AB from 2003 to 2006, Director at Quiatech AB, Independent Director at OssDsign AB from 2016 to 2025, Director at Nuevolution AB, Director at OLIGOvation AB, Director at Sanos Bioscience A, Director at Aprea Therapeutics AB, Deputy Director at Promimic AB from 2016 to 2018, Director at Akinion Pharmaceuticals AB, Director at ClanoTech AB, Director at Neoventa Holding AB, Director at Avidicare AB, Director at SciBase AB, Director at Nuevolution A, Deputy Director at Avidicare Holding AB, Director at Airsonett Holding AB, Director at Ovegun AB, Director at Kanalfläkt Design Alluiq AB, Director at Sjöängensbrygga Ekonomisk Förening, Associate Professor at Karolinska Institutet from 2002 to 2015, Head-Investment Area Life Science at SEB Venture Capital from 2014 to 2016, and Board Member at QuickCool AB. Education includes a doctorate from Karolinska Institutet.

Viktor Drvota active positions

Companies	Position	Start
KDVENTURES AB	Chief Executive Officer	01/06/2017
MODUS THERAPEUTICS HOLDING AB	Chairman	01/01/2016
KDev Investments AB KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments	Chairman	01/05/2017
Dilafor AB Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives	Director/Board Member	01/03/2016
Umecrine Cognition AB Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain	Chief Executive Officer	01/04/2025
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease	Chairman	-
Dilafor Incentive AB	Director/Board Member	-
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Director/Board Member	-
KDev Oncology AB KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology	Director/Board Member	-
░░ ░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

All active positions of Viktor Drvota

Former positions of Viktor Drvota

Companies	Position	End
░░░░░░░░ ░░	░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░ ░░░░░░░ ░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Viktor Drvota's experience

Training of Viktor Drvota

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Viktor Drvota's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	42
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SBL Vaccin AB SBL Vaccin AB Pharmaceuticals: MajorHealth Technology Develops and produces vaccines	Health Technology
SEB Venture Capital SEB Venture Capital Investment ManagersFinance SEB Venture Capital invests in emerging companies located in Sweden. The firm targets companies operating in the fields technology sector, FinTech. It provides financing for early stage capital requirements with an investment size of SEK 10 - 100 million.	Finance
Karolinska Development AB (Private Equity) Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors.	Finance
SciBase Holding AB SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma	Health Technology
Flerie AB Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases	Health Technology
Neoventa Medical AB Neoventa Medical AB Medical SpecialtiesHealth Technology Provides fetal monitoring solutions and obstetric care services	Health Technology
Arexis AB Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Quiatech AB Quiatech AB Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Health Technology
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases	Health Technology
OLIGOvation AB OLIGOvation AB Miscellaneous Commercial ServicesCommercial Services Develops enabling technologies for genetic analysis, molecular diagnostics and gene-based therapeutics	Commercial Services
Sanos Bioscience A/S Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases	Health Technology
Airsonett AB Airsonett AB Medical DistributorsDistribution Services Research and development of a non-pharmaceutical treatment for asthma	Distribution Services
QuickCool AB QuickCool AB Medical SpecialtiesHealth Technology Provides non-invasive brain cooling systems	Health Technology
Aprea Therapeutics AB Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds	Health Technology
Promimic AB Promimic AB Medical SpecialtiesHealth Technology Develops and markets unique coating for medical implants	Health Technology
Dilafor AB Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives	Health Technology
Umecrine Cognition AB Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain	Health Technology
Akinion Pharmaceuticals AB Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia	Health Technology
ClanoTech AB ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration	Health Technology
Karolinska Development AB Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company	Finance
Neoventa Holding AB Neoventa Holding AB MiscellaneousMiscellaneous Operates as a holding company for biotechnology research and development	Miscellaneous
Scibase Intressenter AB
InDex Diagnostics AB InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
KDev Oncology AB KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology	Commercial Services
OssDsign AB OssDsign AB Medical SpecialtiesHealth Technology Designs, manufactures and markets implants for healing and treatment of bone defects	Health Technology
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease	Health Technology
Modus Therapeutics Holding AB Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease	Health Technology
KDev Investments AB KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments	Health Technology
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Health Technology
Avidicare AB Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals.	Distribution Services
Scibase AB
Nuevolution A/S Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology	Commercial Services
Avidicare Holding AB Avidicare Holding AB Medical SpecialtiesHealth Technology Manufactures of medical devices	Health Technology
Airsonett Holding AB
Svenska Vaccinfabriken Produktion AB Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Health Technology
Ovegun AB
Kanalfläkt Design Alluiq AB Kanalfläkt Design Alluiq AB Medical SpecialtiesHealth Technology Manufactures medical and dental instruments	Health Technology
Sjöängensbrygga Ekonomisk Förening
Dilafor Incentive AB
AnaCardio AB AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure	Commercial Services
Uc Research AB